Merck & Co
Merck & Co to buy back $5-bn worth stock
22 May 2013
Merck, the second-largest US drugmaker, will repurchase about 99.5 million shares from Goldman Sachs at current market prices
Delhi HC refuses interim relief to Merck over Glenmark drug
05 Apr 2013
Glenmark said the US drug firm has no patent rights over ‘Sitagliptin Phosphate’, which is used in its anti-diabetes drugs Zita and Zita-Met
Merck & Co forecast profit decline for 2013
02 Feb 2013
China sales, Singulair drive Merck’s Q1-2012 net to $3 bn
28 Apr 2012
Merck's worldwide sales for the first quarter of 2012 rose just one per cent to $11.7 billion due to the unfavorable impact from the arbitration settlement agreement with Johnson & Johnson
Merck to pay $950 million to settle Vioxx drug charges
24 Nov 2011
Vioxx was the centre of a long-running probe by the DoJ for Merck having promoted the painkiller without approval
.webp)
.webp)
